Skip to main content
KROS logo

KROS · Keros Therapeutics, Inc. · Held by Funds

Track KROS — free
$10.08 +0.54 (+5.66%) At close · Nov 12
Market Cap
$197.81M
Shares
19.62M
Volume · Nov 12 630.16K Avg daily vol (3M) 187.94K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of KROS by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 15.52% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.40% 863,149
Index ETFs 11.13% 2,183,268
Active ETFs 2.33% 456,597
Active funds 10.11% 1,984,440
Unclassified 3.62% 711,286
All registered funds 31.59% 6,198,740
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding KROS

162 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 162 positions
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 85 filings 70 filers Visit website Investor relations